Patient characteristics and survival.
收藏官方服务:
资源简介:
OS: median overall survival (weeks). CEE, cyclophosphamide-epirubicin-etoposide. CEV/PE, cyclophosphamide-epirubicin-vincristine alternated with carboplatin-etoposide.
创建时间:
2015-12-02

OS: median overall survival (weeks). CEE, cyclophosphamide-epirubicin-etoposide. CEV/PE, cyclophosphamide-epirubicin-vincristine alternated with carboplatin-etoposide.